APA (7th ed.) Citation

A, A., A, G., F, M., EE, C., J, C., M, S., . . . A, M. (2025). Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study. Advances in therapy, 42(8), 3960. https://doi.org/10.1007/s12325-025-03254-z

Chicago Style (17th ed.) Citation

A, Agiro, Greatsinger A, Mu F, Cook EE, Chen J, Sundar M, Zhao A, Colman E, and Malhotra A. "Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study." Advances in Therapy 42, no. 8 (2025): 3960. https://doi.org/10.1007/s12325-025-03254-z.

MLA (9th ed.) Citation

A, Agiro, et al. "Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study." Advances in Therapy, vol. 42, no. 8, 2025, p. 3960, https://doi.org/10.1007/s12325-025-03254-z.